• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于病毒灭活研究的单击模型。

One-hit models for virus inactivation studies.

作者信息

Kundi M

机构信息

Institute of Environmental Hygiene, University of Vienna, Austria.

出版信息

Antiviral Res. 1999 Apr;41(3):145-52. doi: 10.1016/s0166-3542(99)00008-x.

DOI:10.1016/s0166-3542(99)00008-x
PMID:10320047
Abstract

All biologicals whose production involves materials of human or animal origin are at risk of viral contamination. Testing the capacity of the production processes to remove or inactivate viruses is an essential step in establishing the safety of biological products. The one-hit model which is essentially based on the assumption that the assay will show a positive reaction if and only if there is at least one infectious particle in a small sample drawn from the material, is often used as a basis for the estimation of the number of infectious particles per unit volume, or equivalently, to estimate the ID50 (the dose which results in 50% positive reactions). Due to the availability of computers it is no longer necessary to use inadequate and biased methods like Spearman-Kärber to estimate the ID50. Depending on the details of the experiment the average bias of Spearman Karber ID50 estimates is 10-30%. Maximum likelihood estimation procedures of the parameters, the computation of ID50, reduction factors, and their confidence limits are presented. Furthermore, hints for the design of the experiments are given. The incorporation of kinetics models is also discussed. Although the method represents the state of the art in the biostatistical literature, the problem of random variations of doses has not been addressed appropriately. Based on 36 000 simulated experiments it is shown that the parameters of the model are robust with respect to random variation of doses. Designs using 10-fold dilution series, however, are generally less appropriate and also more affected by dose variability.

摘要

所有生产过程涉及人源或动物源材料的生物制品都有病毒污染的风险。检测生产工艺去除或灭活病毒的能力是确保生物制品安全性的关键步骤。单 hit 模型通常用于估计每单位体积感染性颗粒的数量,或者等效地估计 ID50(导致 50%阳性反应的剂量)。该模型基本上基于这样的假设:从材料中抽取的小样本中,只要存在至少一个感染性颗粒,检测就会呈阳性反应。由于计算机的普及,不再需要使用像 Spearman-Kärber 这样不充分且有偏差的方法来估计 ID50。根据实验细节,Spearman-Kärber ID50 估计值的平均偏差为 10%至 30%。本文介绍了参数的最大似然估计程序、ID50 的计算、降低因子及其置信限。此外,还给出了实验设计的提示。文中还讨论了动力学模型的纳入。尽管该方法代表了生物统计学文献中的最新技术水平,但剂量随机变化的问题尚未得到妥善解决。基于 36000 次模拟实验表明,该模型的参数对剂量的随机变化具有鲁棒性。然而,使用 10 倍稀释系列的设计通常不太合适,并且受剂量变异性的影响也更大。

相似文献

1
One-hit models for virus inactivation studies.用于病毒灭活研究的单击模型。
Antiviral Res. 1999 Apr;41(3):145-52. doi: 10.1016/s0166-3542(99)00008-x.
2
Specific inactivation of viruses which can potentially contaminate blood products.对可能污染血液制品的病毒进行特异性灭活。
Dev Biol Stand. 1991;75:43-52.
3
Analysis of human plasma products: polymerase chain reaction does not discriminate between live and inactivated viruses.
Transfusion. 1997 Sep;37(9):935-40. doi: 10.1046/j.1537-2995.1997.37997454021.x.
4
Effectiveness of alternative treatments for reducing potential viral contaminants from plasma-derived products.替代疗法在减少血浆衍生产品潜在病毒污染物方面的有效性。
Thromb Res. 2002 Mar 1;105(5):391-400. doi: 10.1016/s0049-3848(02)00044-0.
5
Virus inactivation of fresh plasma.新鲜血浆的病毒灭活
Vox Sang. 1998;74 Suppl 2:171-2. doi: 10.1111/j.1423-0410.1998.tb05417.x.
6
Theoretical and technical concerns in inactivation/elimination of viruses in plasma derivatives.血浆衍生物中病毒灭活/清除的理论与技术问题
Dev Biol Stand. 1993;81:117-23.
7
Inactivation of virus in intravenous immunoglobulin G using solvent/detergent treatment and pasteurization.使用溶剂/去污剂处理和巴氏灭菌法灭活静脉注射免疫球蛋白G中的病毒。
Hum Antibodies. 2008;17(3-4):79-84.
8
Validation of purification procedures for removing and/or inactivating viruses in biologicals: points to consider.生物制品中去除和/或灭活病毒的纯化程序验证:需考虑的要点。
Dev Biol Stand. 1991;75:227-32.
9
Solvent/detergent treatment of human plasma--a very robust method for virus inactivation. Validated virus safety of OCTAPLAS.人血浆的溶剂/去污剂处理——一种非常可靠的病毒灭活方法。OCTAPLAS经验证的病毒安全性。
Vox Sang. 1998;74 Suppl 1:207-12. doi: 10.1111/j.1423-0410.1998.tb05474.x.
10
"Absolute" sterility and "absolute" freedom from particle contamination.“绝对”无菌以及“绝对”无颗粒污染。
PDA J Pharm Sci Technol. 1998 Jul-Aug;52(4):173-81.

引用本文的文献

1
Extremely potent human monoclonal antibodies from COVID-19 convalescent patients.来自新冠康复患者的超强效人源单克隆抗体。
Cell. 2021 Apr 1;184(7):1821-1835.e16. doi: 10.1016/j.cell.2021.02.035. Epub 2021 Feb 23.
2
Characterisation of SARS-CoV-2 Lentiviral Pseudotypes and Correlation between Pseudotype-Based Neutralisation Assays and Live Virus-Based Micro Neutralisation Assays.严重急性呼吸综合征冠状病毒2慢病毒假型的表征以及基于假型的中和试验与基于活病毒的微量中和试验之间的相关性
Viruses. 2020 Sep 10;12(9):1011. doi: 10.3390/v12091011.
3
Immunogenicity and protective efficacy of a Vero cell culture-derived whole-virus H7N9 vaccine in mice and guinea pigs.
一种Vero细胞培养衍生的全病毒H7N9疫苗在小鼠和豚鼠中的免疫原性及保护效力
PLoS One. 2015 Feb 26;10(2):e0113963. doi: 10.1371/journal.pone.0113963. eCollection 2015.
4
MVA vectors expressing conserved influenza proteins protect mice against lethal challenge with H5N1, H9N2 and H7N1 viruses.表达保守流感病毒蛋白的MVA载体可保护小鼠免受H5N1、H9N2和H7N1病毒的致死性攻击。
PLoS One. 2014 Feb 11;9(2):e88340. doi: 10.1371/journal.pone.0088340. eCollection 2014.
5
Porcine circovirus (PCV) removal by Q sepharose fast flow chromatography.猪圆环病毒(PCV)通过 Q 琼脂糖快速流层析去除。
Biotechnol Prog. 2013 Nov-Dec;29(6):1464-71. doi: 10.1002/btpr.1804. Epub 2013 Sep 20.
6
H5N1 whole-virus vaccine induces neutralizing antibodies in humans which are protective in a mouse passive transfer model.H5N1 全病毒疫苗可诱导人体产生中和抗体,在小鼠被动转移模型中具有保护作用。
PLoS One. 2011;6(8):e23791. doi: 10.1371/journal.pone.0023791. Epub 2011 Aug 18.
7
A whole virus pandemic influenza H1N1 vaccine is highly immunogenic and protective in active immunization and passive protection mouse models.全病毒 pandemic influenza H1N1 疫苗在主动免疫和被动保护的小鼠模型中具有高度的免疫原性和保护作用。
PLoS One. 2010 Feb 23;5(2):e9349. doi: 10.1371/journal.pone.0009349.
8
A double-inactivated whole virus candidate SARS coronavirus vaccine stimulates neutralising and protective antibody responses.一种双灭活全病毒候选严重急性呼吸综合征冠状病毒疫苗可刺激中和抗体和保护性抗体反应。
Vaccine. 2006 Jan 30;24(5):652-61. doi: 10.1016/j.vaccine.2005.08.055. Epub 2005 Aug 26.